Evidence map›Paper›PMID 32442397›Full record

ArticleMolecular cell2020

HLTF Promotes Fork Reversal, Limiting Replication Stress Resistance and Preventing Multiple Mechanisms of Unrestrained DNA Synthesis.

Gongshi Bai, Chames Kermi, Henriette Stoy, Carl J Schiltz, Julien Bacal, Angela M Zaino, M Kyle Hadden, Brandt F Eichman, Massimo Lopes, Karlene A Cimprich

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 132 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
132citing papers in PubMed, 1 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

132 citing papers in PubMed, 1 synthesis or guideline pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Multi-omics analysis of HLTF context-dependent regulation across TCGA cohorts revealed its potential as new biomarker in tumour.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The Zinc Finger Ran-Binding Protein 3 (ZRANB3): An Advanced Perspective.International journal of molecular sciences · 2026
    Review
  19. Article
  20. Article

72 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Gongshi BaiDepartment of Chemical and Systems Biology, Stanford University School of Medicine, 318 Campus Drive, Stanford, CA 94305-5441, USA.
Chames KermiDepartment of Chemical and Systems Biology, Stanford University School of Medicine, 318 Campus Drive, Stanford, CA 94305-5441, USA.
Henriette StoyInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Carl J SchiltzDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, TN 37232, USA.
Julien BacalDepartment of Chemical and Systems Biology, Stanford University School of Medicine, 318 Campus Drive, Stanford, CA 94305-5441, USA.
Angela M ZainoDepartment of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06029-3092, USA.
M Kyle HaddenDepartment of Pharmaceutical Sciences, University of Connecticut, 69 North Eagleville Road, Storrs, CT 06029-3092, USA.
Brandt F EichmanDepartment of Biological Sciences and Center for Structural Biology, Vanderbilt University, Nashville, TN 37232, USA.
Massimo LopesInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.
Karlene A CimprichDepartment of Chemical and Systems Biology, Stanford University School of Medicine, 318 Campus Drive, Stanford, CA 94305-5441, USA. Electronic address: cimprich@stanford.edu.
Stanford University · USUniversity of Connecticut · USUniversity of Zurich · CHVanderbilt University · US

Funding

Transcription-Coupled & Replication-Associated Excision RepairP01CA092584 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI John A. Tainer · 2001 to 2026
$89.6M
Translational Oncology Research Program (Project-005)P30CA124435 · NCI · STANFORD UNIVERSITY · PI MICHAEL KENNEY · 2007 to 2026
$71.4M
BIOCHEMICAL &CHEMICAL TRAINING FOR CANCER RESEARCHT32CA009582 · NCI · VANDERBILT UNIVERSITY · PI David K Cortez · 1987 to 2026
$8.8M
Regulation of the DNA Damage ResponseR01ES016486 · NIEHS · STANFORD UNIVERSITY · PI CIMPRICH, KARLENE A · 2007 to 2025
$6.2M
The DNA replication-repair interface: mechanisms and regulationR35GM136401 · NIGMS · VANDERBILT UNIVERSITY · PI Brandt F Eichman · 2020 to 2026
$4.3M
Mechanisms of replication fork repairR01GM117299 · NIGMS · VANDERBILT UNIVERSITY · PI EICHMAN, BRANDT F · 2016 to 2019
$1.2M
ImageXpress Micro (IXM) Confocal High-content Imaging SystemS10OD026899 · OD · STANFORD UNIVERSITY · PI SOLOW-CORDERO, DAVID EDWARD · 2019 to 2019
$541k
Upgraded High-Content and High-Throughput siRNA Screening SystemS10RR026338 · NCRR · STANFORD UNIVERSITY · PI SOLOW-CORDERO, DAVID EDWARD · 2010 to 2010
$498k
STAT5 in B cell Acute Lymphoblastic LeukemiaF30CA232399 · NCI · UNIVERSITY OF MINNESOTA · PI LEE, ROBIN D. · 2018 to 2022
$237k
NCI NIH HHS F30 CA232399NCI NIH HHS P01 CA092584NCI NIH HHS P30 CA124435NCI NIH HHS T32 CA009582NCRR NIH HHS S10 RR026338NIEHS NIH HHS R01 ES016486NIGMS NIH HHS R01 GM117299NIGMS NIH HHS R35 GM136401NIH HHS S10 OD026899
6 · The paper itself

Abstract

DNA replication stress can stall replication forks, leading to genome instability. DNA damage tolerance pathways assist fork progression, promoting replication fork reversal, translesion DNA synthesis (TLS), and repriming. In the absence of the fork remodeler HLTF, forks fail to slow following replication stress, but underlying mechanisms and cellular consequences remain elusive. Here, we demonstrate that HLTF-deficient cells fail to undergo fork reversal in vivo and rely on the primase-polymerase PRIMPOL for repriming, unrestrained replication, and S phase progression upon limiting nucleotide levels. By contrast, in an HLTF-HIRAN mutant, unrestrained replication relies on the TLS protein REV1. Importantly, HLTF-deficient cells also exhibit reduced double-strand break (DSB) formation and increased survival upon replication stress. Our findings suggest that HLTF promotes fork remodeling, preventing other mechanisms of replication stress tolerance in cancer cells. This remarkable plasticity of the replication fork may determine the outcome of replication stress in terms of genome integrity, tumorigenesis, and response to chemotherapy.

Indexed as

Cell Line, TumorDNADNA-Binding ProteinsDNA DamageDNA-Directed DNA PolymeraseDNA PrimaseDNA RepairDNA ReplicationHEK293 CellsHumansK562 CellsMultifunctional EnzymesNucleotidyltransferasesTranscription FactorsY-Family DNA PolymerasesDNADNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA PrimaseHLTF protein, humanMultifunctional EnzymesNucleotidyltransferasesPrimPol protein, humanREV1 protein, humanTranscription FactorsY-Family DNA PolymerasesDNA replication, replication stress response, fork reversal, HLTF, PRIMPOL, REV1, DNA damage tolerance, translesion synthesis, ATR inhibition, replication catastrophe

Identifiers

PMID32442397
PMCPMC7305998
OpenAlexW3026131189

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.